RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2004288143 (hide)

Owner Sirna Therapeutics, Inc.

Inventors McSwiggen, James

Agent Spruson & Ferguson

Pub. Number AU-A-2004288143

PCT Pub. Number WO2005/045036

Priority 10/825,485 15.04.04 US; 60/543,480 10.02.04 US; US04/13456 30.04.04 US; 10/693,059 23.10.03 US; 10/727,780 03.12.03 US; 10/826,966 16.04.04 US; 10/832,522 26.04.04 US; US04/16390 24.05.04 US; 10/780,447 13.02.04 US; 10/757,803 14.01.04 US; 10/720,448 24.11.03 US; 10/830,569 23.04.04 US

Filing date 18 August 2004

Wipo publication date 19 May 2005

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/045036 Priority application(s): WO2005/045036

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288157-Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells

2004288139-Compact, integrated system for processing test samples